de la Cruz-Merino, L.; Gion, M.; Cruz-Jurado, J.; Quiroga, V.; Andrés, R.; Moreno, F.; Alonso-Romero, J.L.; Ramos, M.; Holgado, E.; Cortés, J.;
et al. Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study. Cancers 2021, 13, 5432.
https://doi.org/10.3390/cancers13215432
AMA Style
de la Cruz-Merino L, Gion M, Cruz-Jurado J, Quiroga V, Andrés R, Moreno F, Alonso-Romero JL, Ramos M, Holgado E, Cortés J,
et al. Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study. Cancers. 2021; 13(21):5432.
https://doi.org/10.3390/cancers13215432
Chicago/Turabian Style
de la Cruz-Merino, Luis, MarÃa Gion, Josefina Cruz-Jurado, Vanesa Quiroga, Raquel Andrés, Fernando Moreno, Jose L. Alonso-Romero, Manuel Ramos, Esther Holgado, Javier Cortés,
and et al. 2021. "Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study" Cancers 13, no. 21: 5432.
https://doi.org/10.3390/cancers13215432
APA Style
de la Cruz-Merino, L., Gion, M., Cruz-Jurado, J., Quiroga, V., Andrés, R., Moreno, F., Alonso-Romero, J. L., Ramos, M., Holgado, E., Cortés, J., López-Miranda, E., Henao-Carrasco, F., Palazón-Carrión, N., RodrÃguez, L. M., Ceballos, I., Casas, M., Benito, S., Chiesa, M., Bezares, S.,
... Rojo, F.
(2021). Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study. Cancers, 13(21), 5432.
https://doi.org/10.3390/cancers13215432
